ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021
April 13, 2021Alphamab Oncology announced that data from phase Ib/II clinical study (clinical trial No.: KN046-203) of PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel for the treatment of patients with metastatic triple-negative breast ...
Pharma Sources Insight January 2025
